Mark A. Babizhayev
Innovative Vision Products, Inc., 3511 Silverside Road, Suite 1 05,
County of New Castle, Delaware USA 19810
• | Presbyopia. |
• | Open-angle primary glaucoma (in combination with beta-blockers). |
• | Corneal disorders. |
• | Computer vision syndrome. |
• | Eyestrain |
• | Ocular inflammation. |
• | Blurred vision. |
• | Dry eye syndrome. |
• | Retinal diseases. |
• | Vitreous opacities and lesions. |
• | Complications of diabetes mellitus and other systemic diseases. |
• | Contact lens difficulties, particularly with soft contact lenses. (Not only do the lubricants in the Can-C TM N-acetylcarnosine eye-drop help to make wearing contact lenses more comfortable, but n-acetylcarnosine is also able to reduce the build up of lactic acid in the eye, thus providing the lens to be left safely in the eye for longer). |
Innovative Vision Products, Inc. is a holder of the worldwide patent (including PCT International Publication Number WO 2004/028536 A1) for the application of N-acetylcarnosine for the treatment of ophthalmic disorders including cataracts.
PDF Fulltext XML References
How to cite this article
Mark A. Babizhayev, 2006. Ophthalmic Pharmacology of N-acetylcarnosine Lubricant Eye Drops. Journal of Pharmacology and Toxicology, 1: 201-233.
DOI: 10.3923/jpt.2006.201.233
URL: https://scialert.net/abstract/?doi=jpt.2006.201.233
DOI: 10.3923/jpt.2006.201.233
URL: https://scialert.net/abstract/?doi=jpt.2006.201.233